SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
Cardiff Oncology released interim results from its randomized Phase 2 CRDF-004 trial evaluating onvansertib combined with standard chemotherapy and bevacizumab for first-line RAS-m…
Rocket One Inc. announced the appointment of Major General Malcolm B. Frost (Ret.) to its Space and Defense Advisory Board, bringing nearly four decades of military and national se…
Rocket One Inc., a Nevada corporation, filed an 8-K regarding an at-the-market offering of up to $6,829,000 in common stock through sales agent H.C. Wainwright & Co., LLC under a F…
USA Rare Earth, Inc. entered into a direct funding agreement with the U.S. Department of Commerce dated June 3, 2026, for the Round Top and Stillwater projects with Award ID AP-202…
TransCode Therapeutics announced positive Phase 1a results for its lead candidate TTX-MC138, showing safety, tolerability, and disease stabilization in metastatic cancer patients a…
Rent the Runway reported Q1 2026 results with total revenue of $89.9 million, up 29.2% year-over-year, while add-on revenue surged 70.4% YoY. The company also announced leadership …
RadNet announced plans to secure a $200 million incremental term loan to fund acquisitions, organic expansion, and health system partnerships. The financing demonstrates the compan…
BioLife Solutions released a June 2026 investor presentation outlining its industry-leading solutions for cell-based therapies. The presentation includes financial metrics, non-GAA…
Richtech Robotics completed acquisition of a 79,325 sq ft Las Vegas facility for $21.2M to support AI infrastructure and robotics operations across its three strategic business pil…
1606 Corp executed a Third Amendment to its Purchase and Sale Agreement with Jefferson Enterprise Energy, LLC, extending the acquisition closing deadline while maintaining financin…
Digi Power X secured a $35 million commitment to purchase NVIDIA's next-generation Vera Rubin GPU systems for deployment in Q1 2027 to expand its NeoCloudz GPU-as-a-Service platfor…
NewAmsterdam Pharma Company N.V. has adopted an Employee Stock Purchase Plan (ESPP) authorizing up to 1,150,000 shares for eligible employees under IRC Section 423. The plan allows…
Dyne Therapeutics announced full enrollment in the registrational expansion cohort of its ACHIEVE trial for Z-basivarsen, with topline data expected in Q1 2027 to support potential…
TG Therapeutics announced positive pharmacokinetic and pharmacodynamic results from a Phase 1 trial of subcutaneous BRIUMVI, demonstrating greater than 60% bioavailability and supp…
GlobalTech Corp issued a shareholder update emphasizing disciplined execution, transparent reporting, and responsible AI innovation rather than predictive guidance. The company com…
Destination XL Group's Board is renegotiating its merger of equals with FullBeauty Brands, citing challenging consumer environment and FullBeauty's debt levels since the December 2…
Destination XL Group reported Q1 FY2026 sales of $103.3 million with net loss of $5.9 million ($0.11 per diluted share), as comparable store sales declined 3.8% year-over-year. The…
Avalyn completed an upsized IPO raising $345 million gross proceeds and reported progress on three pulmonary fibrosis programs, with MIST Phase 2b enrollment on track for mid-2026 …
Sprinklr delivered solid first-quarter results with 7% total revenue growth and 6% subscription revenue growth, achieving $70.4M in operating cash flow and $65.8M in free cash flow…
Ollie's reported 14% net sales growth and 19% EPS growth in Q1 FY2026, exceeding expectations with margin expansion and strong comparable store sales. The company raised fiscal 202…